Compare GOAI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOAI | CGTX |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 122.9M | 132.4M |
| IPO Year | N/A | 2021 |
| Metric | GOAI | CGTX |
|---|---|---|
| Price | $3.27 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 311.2K | ★ 984.9K |
| Earning Date | 04-10-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $15,656,703.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.37 | ★ N/A |
| Revenue Growth | ★ 86.84 | N/A |
| 52 Week Low | $1.32 | $0.22 |
| 52 Week High | $18.00 | $3.83 |
| Indicator | GOAI | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 33.41 |
| Support Level | N/A | $1.08 |
| Resistance Level | N/A | $1.49 |
| Average True Range (ATR) | 0.00 | 0.09 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 11.49 |
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.